SAB Members

Koussay Dellagi

Hechmi Louzir

Marc Bonneville

Hechmi Louzir
Dr. Koussay Dellagi is a distinguished Tunisian physician and immunologist renowned for his extensive research in infectious diseases. He earned his medical degree in 1973, specializing in clinical hematology, and later obtained a Doctorate of State in Immunology from Paris University. Throughout his illustrious career, Dr. Dellagi has held several prominent positions, including Director General of the Institut Pasteur de Tunis (1988–2007), Managing Director of the Centre de Recherche et de Veille sur les Maladies Emergentes dans l’Océan Indien in Réunion, France (2007–2015), and Scientific Advisor at the Department of International Affairs, Institut Pasteur, and subsequently at the Association Pasteur Network in Paris (2015–2023). His research primarily focuses on the epidemiology, pathophysiology, transmission, control, and prevention of infectious diseases. Dr. Dellagi has contributed to over 500 publications and has been cited more than 8,500 times, reflecting his significant impact on the field.
Koussay Dellagi
Dr. Koussay Dellagi is a distinguished Tunisian physician and immunologist renowned for his extensive research in infectious diseases. He earned his medical degree in 1973, specializing in clinical hematology, and later obtained a Doctorate of State in Immunology from Paris University. Throughout his illustrious career, Dr. Dellagi has held several prominent positions, including Director General of the Institut Pasteur de Tunis (1988–2007), Managing Director of the Centre de Recherche et de Veille sur les Maladies Emergentes dans l’Océan Indien in Réunion, France (2007–2015), and Scientific Advisor at the Department of International Affairs, Institut Pasteur, and subsequently at the Association Pasteur Network in Paris (2015–2023). His research primarily focuses on the epidemiology, pathophysiology, transmission, control, and prevention of infectious diseases. Dr. Dellagi has contributed to over 500 publications and has been cited more than 8,500 times, reflecting his significant impact on the field.
Mark Bonneville
Marc Bonneville, DVM, PhD, is a distinguished immunologist renowned for his extensive research in immunology, oncology, and infectious diseases. Dr. Bonneville has held several prominent positions throughout his career, including Director of the INSERM Cancer Research Center in Nantes/Angers and Director of the Pays de la Loire branch of the French Blood Bank. In 1999, he co-founded Innate Pharma, a biotechnology company focused on developing innovative immunotherapies targeting innate lymphocytes in infectious diseases and oncology. In 2013, Dr. Bonneville joined Institut Mérieux as Vice President of Medical and Scientific Affairs. Three years later, in 2016, he was appointed Chairman of the Alliance for Research and Innovation in the Healthcare Industries (ARIIS), an organization affiliated with the French Health Industry Federation (FEFIS) aimed at fostering synergy across various healthcare sectors. Throughout his career, Dr. Bonneville has authored over 200 scientific publications and co-signed multiple patents. His contributions have been recognized with several awards, including the CNRS Bronze and Silver Medals.